All affiliations or financial involvement (e.g., employment, consultancies, honoraria, stock ownership or options, expert testimony, grants, patents received or pending, royalties) with any organization or entity with a financial interest in, or in financial competition with, the subject matter or materials discussed in the manuscript must be completely disclosed in the submitted manuscript.
All financial and material support for the research and work must be clearly identified in the manuscript including listing of support that might constitute or give the appearance of influencing the findings. Report all support for the work reported in your manuscript without time limit. For all other items, the time frame for disclosure is the past 36 months.
All authors are expected to provide disclosures to the corresponding author before submission for inclusion in the “Conflict of Interest” statement. Items included in the disclosure statement should cover: consulting fees or paid advisory boards (for the past three years or the known future), equity ownership/stock options (publicly or privately traded firms, excluding mutual funds), lecture fees when speaking at the invitation of a commercial sponsor (for the past three years or the known future), employment by the commercial entity that sponsored the study, grant support from industry, patents and/or royalties, expert witness, and other activities performed for a commercial sponsor.
For detailed instructions on how conflicts should be disclosed in manuscript submissions, please see our Instructions to Authors.
Financial Disclosure of Executive Board Members
The leadership of JAD will disclose any relevant relationships per the journal’s disclosure policy. These disclosures are updated every 6 months and are available here: http://www.j-alz.com/boarddisclosures
